BP
MOH icon

Ballentine Partners’s Molina Healthcare MOH Stock Holding History

Ballentine Partners’s Portfolio MOH Stock Details MOH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,293
Closed -$981K – 1049
2025
Q2 		$981K Buy
3,293
+25
+0.8% +$7.85K 0.01% 325
2025
Q1 		$1.08M Buy
3,268
+105
+3% +$31.7K 0.02% 277
2024
Q4 		$921K Buy
3,163
+226
+8% +$69.8K 0.02% 302
2024
Q3 		$1.01M Buy
2,937
+9
+0.3% +$2.97K 0.02% 276
2024
Q2 		$870K Sell
2,928
-96
-3% -$32.6K 0.02% 293
2024
Q1 		$1.24M Buy
3,024
+60
+2% +$23.2K 0.02% 207
2023
Q4 		$1.07M Buy
2,964
+24
+0.8% +$8.46K 0.02% 220
2023
Q3 		$964K Buy
2,940
+41
+1% +$12.9K 0.02% 204
2023
Q2 		$873K Buy
2,899
+119
+4% +$34.2K 0.02% 216
2023
Q1 		$744K Buy
+2,780
New +$799K 0.02% 233

Other funds holding MOH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ballentine Partners's MOH Position: Q3 2025 in Review

Ballentine Partners sold out of Molina Healthcare (MOH) in Q3 2025, closing a stake of 3,293 shares — an estimated $981K sold.

Ballentine Partners first reported a position in MOH in Q1 2023 and held it in 10 quarters. The position peaked at $1.24M in Q1 2024. 626 funds tracked by Wall St. Rank hold MOH as of Q3 2025.

  • Ballentine Partners reported no remaining Molina Healthcare position as of Q3 2025 after selling out during the quarter.
  • Ballentine Partners sold 3,293 Molina Healthcare shares in Q3 2025, an estimated $981K.
  • Ballentine Partners first reported a position in Molina Healthcare in Q1 2023 and held it in 10 quarters.
  • Ballentine Partners's Molina Healthcare position peaked at $1.24M in Q1 2024.
  • 626 funds tracked by Wall St. Rank held Molina Healthcare as of Q3 2025.

Based on Ballentine Partners's 13F filing for Q3 2025, filed 3 Nov 2025.